This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Nottingham. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Andrew Fogarty: Innovator in Biomarkers for Infection Detection
Introduction
Andrew Fogarty is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of infections caused by Pseudomonas aeruginosa. His innovative approach has the potential to improve patient outcomes through more accurate and timely diagnosis.
Latest Patents
Andrew Fogarty holds a patent titled "Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof." This patent describes a method for determining the infection status of a subject by analyzing a sample of material obtained from them. The method involves determining the level of one or more alkyl quinolones or their metabolites produced by Pseudomonas aeruginosa or related species in the sample. This innovative technique represents a significant advancement in the field of infection diagnostics.
Career Highlights
Andrew Fogarty is affiliated with The University of Nottingham, where he conducts research and develops new diagnostic methods. His work is characterized by a commitment to improving healthcare through scientific innovation. With a focus on practical applications, he aims to bridge the gap between research and clinical practice.
Collaborations
Andrew has collaborated with esteemed colleagues, including Miguel Camara and Paul Williams. These partnerships have fostered a collaborative environment that enhances the research and development of new diagnostic tools.
Conclusion
Andrew Fogarty's contributions to the field of infection detection through his innovative patent highlight the importance of research in improving healthcare outcomes. His work exemplifies the potential of scientific advancements to transform medical diagnostics.